Cargando…
Probucol, a “non-statin” cholesterol-lowering drug, ameliorates D-galactose induced cognitive deficits by alleviating oxidative stress via Keap1/Nrf2 signaling pathway in mice
Oxidative stress plays a vital role in the initiation and progression of age-related neurodegenerative diseases. Ameliorating oxidative damage is therefore considered as a beneficial strategy for the treatment of age-related neurodegenerative disorders. Probucol (Prob), a lipid-lowering prototype ag...
Autores principales: | Huang, Jin-Lan, Yu, Chao, Su, Min, Yang, Si-Man, Zhang, Fan, Chen, Yuan-Yuan, Liu, Jin-Yuan, Jiang, Yi-Fan, Zhong, Zhen-Guo, Wu, Deng-Pan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6814622/ https://www.ncbi.nlm.nih.gov/pubmed/31590160 http://dx.doi.org/10.18632/aging.102337 |
Ejemplares similares
-
Probucol inhibits the initiation of atherosclerosis in cholesterol-fed rabbits
por: Niimi, Manabu, et al.
Publicado: (2013) -
Probucol Prevents Diabetes-Induced Retinal Neuronal Degeneration through Upregulating Nrf2
por: Liu, Heng-Wei, et al.
Publicado: (2020) -
Probucol alleviates atherosclerosis and improves high density lipoprotein function
por: Zhong, Jian-Kai, et al.
Publicado: (2011) -
Effects of calcium dobesilate on Nrf2, Keap1 and HO-1 in the lenses of D-galactose-induced cataracts in rats
por: Sun, Jinfeng, et al.
Publicado: (2018) -
Add-On Effect of Probucol in Atherosclerotic, Cholesterol-Fed Rabbits Treated with Atorvastatin
por: Keyamura, Yuka, et al.
Publicado: (2014)